https://www.marketscreener.com/quote/stock/BRIDGEBIO-PHARMA-INC-60342525/news/BridgeBio-Pharma-Inc-completed-the-acquisition-of-remaining-36-3-stake-in-Eidos-Therapeutics-Inc-33549804/?utm_source=telegram&utm_medium=social&utm_campaign=share